Home Compliance FCA Suit Alleging Manufacturer Fraudulently Induced HHS to Stockpile $1.4B of Tamiflu... ComplianceExpert OpinionFCANews FCA Suit Alleging Manufacturer Fraudulently Induced HHS to Stockpile $1.4B of Tamiflu to Prevent Influenza Pandemic Allowed to Proceed October 8, 2020 28 Share FacebookLinkedinTwitter matsiukpavel | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). More at Crowell & Moring RELATED ARTICLESMORE FROM AUTHOR Compliance When Advocacy Turns Into Obstruction: A Cautionary Tale for Corporate Counsel Handling Gov’t Investigations Compliance March 2024 Developments Under President Biden’s Cybersecurity Executive Order, National Cybersecurity Strategy, and AI Executive Order Compliance Wages War Over: Ohio Court Rules SCA Violations Weren’t FCA Violations